Most pharmaceutical companies spend lots of money in the beginning to develop new drugs to put on the market. Eagle Pharmaceuticals (NASDAQ:EGRX) takes a different approach. They look for injectable drugs that are about to lose patent protection, make them better, and sell the improved drugs. That makes it much cheaper and faster to develop their drugs.
The official website for Eagle Pharmaceuticals is www.eagleus.com.
I purchased a position of EGRX on August 15 for $60.01 a share. I think the stock is a good buy under $63 per share. I plan to hold EGRX for at least one year.
Disclaimer and disclosures: As with all investment information, you should do your own research and/or consult with a professional before making investment decisions. Remember, it’s your money. The information provided here represents my personal opinions. I own shares of EGRX.